MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 29.02.2024
PetIQ Gesamtverbindlichkeiten 2011-2026 | PETQ
Gesamtverbindlichkeiten Jährlich PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 478 M | 344 M | 174 M | 36 M | 40.3 M | 46.1 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 478 M | 36 M | 186 M |
Gesamtverbindlichkeiten anderer Aktien in der Arzneimittelhersteller
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
10.3 B | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
10.5 M | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
52.3 M | $ 5.59 | -0.27 % | $ 83 M | USA |
 |
HEXO Corp.
HEXO
|
367 M | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
250 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
12.7 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
63.2 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
11.6 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
449 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
26.6 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
107 M | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
54.2 M | $ 2.62 | -2.24 % | $ 1 B | Canada |
 |
Athenex
ATNX
|
228 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
347 M | $ 38.91 | 3.37 % | $ 1.43 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
90.4 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
6.15 B | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
173 M | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
165 M | $ 2.38 | 1.92 % | $ 302 M | USA |
 |
Canopy Growth Corporation
CGC
|
430 M | $ 0.97 | -2.64 % | $ 104 M | Canada |
 |
Pacira BioSciences
PCRX
|
775 M | $ 22.87 | -0.52 % | $ 1.06 B | USA |
 |
Aurora Cannabis
ACB
|
244 M | $ 3.02 | -0.63 % | $ 166 M | Canada |
 |
Solid Biosciences
SLDB
|
52.5 M | $ 7.18 | 0.56 % | $ 628 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
9.28 M | $ 1.13 | 3.21 % | $ 1.4 M | USA |
 |
Jupiter Wellness
JUPW
|
5.98 M | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
735 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
102 M | $ 1.03 | -2.36 % | $ 98.2 M | Canada |
 |
Tilray
TLRY
|
977 M | $ 5.04 | 1.1 % | $ 3.11 B | Canada |
 |
Evolus
EOLS
|
249 M | $ 6.67 | -0.89 % | $ 430 M | USA |
 |
Sundial Growers
SNDL
|
235 M | $ 1.41 | -1.06 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
796 M | $ 8.28 | -0.48 % | $ 443 M | USA |
 |
Veru
VERU
|
11.5 M | $ 3.1 | 3.47 % | $ 45.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
23.7 M | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
3.19 M | $ 0.69 | 0.89 % | $ 2.78 M | USA |
 |
Assertio Holdings
ASRT
|
173 M | $ 23.5 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
56.4 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
434 M | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
26 B | $ 5.01 | -0.89 % | $ 1.86 B | Canada |
 |
Relmada Therapeutics
RLMD
|
7.49 M | $ 6.59 | -0.9 % | $ 260 M | USA |
 |
Recro Pharma
REPH
|
94.8 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
169 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
9.65 M | $ 4.2 | -0.71 % | $ 210 M | USA |
 |
PLx Pharma
PLXP
|
25 M | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
22.5 B | $ 16.36 | -0.7 % | $ 19.1 B | USA |
 |
Zomedica Corp.
ZOM
|
11.6 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
9.29 M | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
20.2 M | $ 0.66 | 5.44 % | $ 23.7 M | USA |
 |
Tricida
TCDA
|
168 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
8.26 M | $ 0.76 | 2.34 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
10.8 M | $ 2.29 | 4.18 % | $ 26.5 M | USA |